At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PTIX Protagenic Therapeutics Inc
Pre-Market Trading 11-05 08:40:17 EST
0.6070
-0.0012
-0.20%
High0.6385
Low0.6070
Vol26.72K
Open0.6385
D1 Closing0.6082
Amplitude5.18%
Mkt Cap2.71M
Tradable Cap1.98M
Total Shares4.47M
T/O16.35K
T/O Rate0.82%
Tradable Shares3.26M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Protagenic Therapeutics Prices $1.3 Million Placement
Protagenic Therapeutics' Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychiatric Disorders
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.